《“新冠疫情与细菌感染：微生物学和临床方面”特刊社论》
Editorial of Special Issue "The COVID-19 Pandemic and Bacterial Infections: Microbiological and Clinical Aspects".
作者信息
Di Pilato Vincenzo, Giacobbe Daniele Roberto
机构信息
Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, 16132 Genoa, Italy.
Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
出版信息
Microorganisms. 2023 Apr 12;11(4):1009. doi: 10.3390/microorganisms11041009.
Abstract
The emergence in late 2019 of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the pandemic coronavirus disease 2019 (COVID-19), posed significant health challenges worldwide [...].
摘要
2019年末，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）出现，它是2019年冠状病毒病（COVID-19）的病原体，给全球带来了重大健康挑战[...]。
相似文献
1
Editorial of Special Issue "The COVID-19 Pandemic and Bacterial Infections: Microbiological and Clinical Aspects".《“新冠疫情与细菌感染：微生物学和临床方面”特刊社论》
Microorganisms. 2023 Apr 12;11(4):1009. doi: 10.3390/microorganisms11041009.
2
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
3
COVID-19: a conundrum to decipher.COVID-19：一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
4
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.2019 冠状病毒病（COVID-19）大流行与妊娠。
Am J Obstet Gynecol. 2020 Jun;222(6):521-531. doi: 10.1016/j.ajog.2020.03.021. Epub 2020 Mar 23.
5
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.巴西原住民中由严重急性呼吸综合征冠状病毒2感染或其他病原体引起的严重急性呼吸综合征：一项关于冠状病毒病（COVID）-19大流行第一年的观察性研究。
Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7.
6
Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.氧化应激作为严重急性呼吸综合征冠状病毒（SARS-CoV）感染的关键因素。
Arch Med Res. 2020 Jul;51(5):384-387. doi: 10.1016/j.arcmed.2020.04.019. Epub 2020 Apr 30.
7
Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans.牛和猪呼吸道冠状病毒与人类 SARS-CoV-2 在动物宿主物种中的比较发病机制。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01355-20.
8
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2（SARS-CoV-2）的爆发：当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
9
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.从单个细菌人工染色体中拯救 SARS-CoV-2。
mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20.
10
A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region.一项关于 COVID-19 大流行对伦巴第地区意大利住院医师培训和生活质量影响的横断面调查研究。
Ann Med. 2022 Dec;54(1):2326-2339. doi: 10.1080/07853890.2022.2105392.
引用本文的文献
1
Hospital antimicrobial stewardship: profiling the oral microbiome after exposure to COVID-19 and antibiotics.医院抗菌药物管理：新冠病毒感染及抗生素暴露后口腔微生物群特征分析
Front Microbiol. 2024 Feb 27;15:1346762. doi: 10.3389/fmicb.2024.1346762. eCollection 2024.
2
Changes in the Prevalence of Infection in Pregnant Women during the COVID-19 Lockdown.新冠疫情封锁期间孕妇感染率的变化
Microorganisms. 2023 Jul 31;11(8):1973. doi: 10.3390/microorganisms11081973.
本文引用的文献
1
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者的抗菌药物耐药性：系统评价和荟萃分析。
Lancet Microbe. 2023 Mar;4(3):e179-e191. doi: 10.1016/S2666-5247(22)00355-X. Epub 2023 Jan 31.
2
Too many antibiotics for patients with COVID-19 despite low bacterial infections.尽管细菌感染率低，但新冠肺炎患者使用的抗生素却过多。
Lancet Infect Dis. 2023 Jun;23(6):636-637. doi: 10.1016/S1473-3099(22)00866-0. Epub 2023 Jan 27.
3
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial.抗菌药物管理前瞻性审核和反馈对 COVID-19 住院患者的疗效和安全性（COVASP）：一项实用的、基于群组的、非劣效性试验。
Lancet Infect Dis. 2023 Jun;23(6):673-682. doi: 10.1016/S1473-3099(22)00832-5. Epub 2023 Jan 27.
4
Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.新冠病毒感染患者的细菌合并感染率和抗生素使用模式：系统评价和荟萃分析。
PLoS One. 2022 Aug 1;17(8):e0272375. doi: 10.1371/journal.pone.0272375. eCollection 2022.
5
Changes in Invasive and Infections in France during the COVID-19 Pandemic.新冠疫情期间法国侵袭性感染情况的变化
Microorganisms. 2022 Apr 26;10(5):907. doi: 10.3390/microorganisms10050907.
6
High Rates of Bacterial Pulmonary Co-Infections and Superinfections Identified by Multiplex PCR among Critically Ill COVID-19 Patients.多重PCR在危重症COVID-19患者中发现的细菌肺部合并感染和重叠感染率高。
Microorganisms. 2021 Nov 30;9(12):2483. doi: 10.3390/microorganisms9122483.
7
Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS.镇静剂和神经肌肉阻滞剂在患有新型冠状病毒肺炎急性呼吸窘迫综合征的机械通气患者中的应用
Microorganisms. 2021 Nov 20;9(11):2393. doi: 10.3390/microorganisms9112393.
8
Pneumonia: A Rare Cause of Infection in a Patient with COVID-19.肺炎：新型冠状病毒肺炎患者感染的罕见原因
Microorganisms. 2021 Nov 17;9(11):2369. doi: 10.3390/microorganisms9112369.
9
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
10
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染：一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
Zotero 插件